Combination Therapy Boosts Immune Attack Against Prostate Cancer

Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells. Authors: Wang S, Huang M, Chen M, Sun Z, Jiao Y, Ye G, Pan J, Ye W, Zhao J, Zhang D Journal: Journal f…